Our results show that N-fMLP triggers the activation of FPR1/TrkA(Y490)/MAPK/ERKs cascade, suggesting that FPR1-mediated ERK activation might represent a promising therapeutical approach for BD treatment. Here, NTRK1 is linked to Behcet disease.